Endovascular

View the latest content related to this topic

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

(UPDATED) The first of its kind RCT in acute intermediate-high-risk PE used a surrogate endpoint, but more data are on the horizon.

Caitlin E. Cox

October 26, 2025

Slides

See all

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

Presentation Miami Valves 2025

Something in the Way: An RV in Crisis

Presenter: Enrique Soltero Mariscal

January 30, 2025

Presentation Miami Valves 2025

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

Presenter: Lourdes Villarrubia Varela

January 30, 2025

Presentation Cardiovascular Interventions 2024

Building Your PERT Team: Designing the Right Team with the Right Technology

Presenter: Curtiss T. Stinis

November 11, 2024

News

See all

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

By Michael O'Riordan

November 05, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

By Caitlin E. Cox

November 03, 2025

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

By L.A. McKeown

October 29, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

By L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

By Caitlin E. Cox

October 26, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Endovascular

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Slides

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Something in the Way: An RV in Crisis

A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement

Building Your PERT Team: Designing the Right Team with the Right Technology

News

What’s Going to Be Hot at AHA 2025?

TCTMD’s Top 10 Most Popular Stories for October 2025

CMS Greenlights Reimbursement for Renal Denervation Systems

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Endovascular

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content